Barry Flannelly
Directeur/Bestuurslid bij PROTARA THERAPEUTICS, INC.
Vermogen: 4 M $ op 30-04-2024
Actieve functies van Barry Flannelly
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INCYTE CORPORATION | Corporate Officer/Principal | 01-08-2014 | - |
| PROTARA THERAPEUTICS, INC. | Directeur/Bestuurslid | 23-07-2020 | - |
| Independent Dir/Board Member | 23-07-2020 | - |
Loopbaan van Barry Flannelly
Eerdere bekende functies van Barry Flannelly
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GENOMIC HEALTH, INC. | Directeur/Bestuurslid | 16-04-2019 | 08-11-2019 |
| OSS Healthcare, Inc. | Algemeen Directeur | 01-08-2013 | 01-07-2014 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01-04-2011 | 01-04-2013 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01-08-2008 | 01-01-2011 |
| Johns Hopkins Oncology Center | Corporate Officer/Principal | - | - |
Opleiding van Barry Flannelly
| Massachusetts College of Pharmacy & Health Science | Undergraduate Degree |
| University of Baltimore | Masters Business Admin |
| University of Maryland School of Pharmacy | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 11 |
Operationeel
| Corporate Officer/Principal | 4 |
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| PROTARA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Genomic Health, Inc.
 Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
| OSS Healthcare, Inc. | |
| Johns Hopkins Oncology Center |
- Beurs
- Insiders
- Barry Flannelly
- Ervaring
